Friday, 4 September 2026European Markets
Source trace. Via News points to the documents behind its reporting and shows what we drew from each — so you can check any claim. How we source
Source document· May 13, 2026

Should You Buy, Sell or Hold NEM Stock After a 36% Rally in 6 Months?

View original at finance.yahoo.com
“At the end of the first quarter of 2026, Newmont had robust liquidity of roughly $12.8 billion, including cash and cash equivalents of around $8.8 billion.”
Verbatim excerpt from the source · short snapshot — read the full document at the original

What we drew from this source

The claims Via News extracted from this document. We point to the source; we don't replace it.

  • Newmont reduced debt by roughly $3.4 billion in 2025 and by an additional $42 million in Q1 2026, resulting in a net cash position of $3.2 billion

    60% confidence
  • The NEM stock has been trading above its 200-day SMA since April 9, 2025, and broke above its 50-day SMA on May 6, 2026, with a golden crossover on April 16, 2025, indicating a bullish trend

    60% confidence
  • Ahafo North is expected to produce between 275,000 and 325,000 ounces of gold annually over an estimated mine life of 13 years, with output of 315,000 ounces expected in 2026

    60% confidence
  • At end of Q1 2026, Newmont had liquidity of roughly $12.8 billion including cash and cash equivalents of around $8.8 billion

    60% confidence
  • NEM has distributed $3.4 billion to shareholders through dividends and share repurchases in 2025, and returned $2.7 billion since February 19, 2026

    60% confidence
  • NEM stock has outperformed the Zacks Mining – Gold industry's 22.4% gain and the S&P 500's increase of 11.8%, while gold mining peers Barrick, Agnico Eagle, and Kinross gained 23.8%, 17.2%, and 24.7% respectively

    60% confidence
  • Newmont executed $6 billion in repurchases under prior share purchase programs including $2.4 billion since the Q4 2025 earnings call; board has approved an additional $6 billion repurchase program

    60% confidence
  • Free cash flow surged 161% year over year to a record $3.1 billion in Q1 2026, with net cash from operating activities of $3.8 billion versus $2 billion in the year-ago quarter

    60% confidence
  • Newmont shares have climbed 36.3% in the past six months, fueled by an upswing in gold prices amid economic and geopolitical uncertainties and its forecast-topping earnings performance

    60% confidence
  • Newmont's dividend yield of 0.9% and payout ratio of 12% indicate the dividend is safe and reliable, backed by strong cash flows

    60% confidence
  • Newmont generated $3.6 billion from portfolio optimization actions in 2025 to support capital allocation strategy focused on balance sheet reinforcement and shareholder returns

    60% confidence

Data points we hold from this source

Newmont Corporation · margin12 percent
Newmont Corporation · market share0.9 percent
Newmont Corporation · debt-42 USD
Newmont Corporation · net income3.1 USD
Newmont Corporation · cash8.8 USD
Newmont Corporation · debt-3.4 USD
What we know · the intelligence behind this page
Live from the substrate
What we're seeing
AI Funding Surge: Capital Floods Fintech, Foundation Models, and Autonomous Systems
A concentrated burst of AI-linked funding on 2026-08-28 pushed well over $1.5B into companies spanning fraud/identity fintech (Socure, which also acquired Fravity), foundation models (Stability AI), AI agents and enterprise tooling (Instinct, Generalist AI, Emerald AI, Owner), and AI-adjacent autonomous/aerospace ventures (Gatik, Regent Craft). The breadth and simultaneity of these rounds signal that investor appetite for AI is not concentrated in a single vertical but is broadening into applied and infrastructure-adjacent domains, with consolidation (Socure-Fravity) beginning alongside fresh capital formation.
Our read on the data ›
Signals we're tracking
EPKINLY Regulatory-Clinical Success Cascade
High probability of expanded label indications, additional combination approvals, and competitive positioning strength in follicular lymphoma market. Predicts positive commercial uptake and potential accelerated review for related indications.
Patterns we're watching ›
Where sources disagree
Morgan Stanley & Co. LLC
The same metric (eps) for the same entity (Morgan Stanley & Co. LLC) reported for the identical fiscal period (Q1 2026) and observation date (2026-03-31) has two conflicting values: 3.43 USD_per_share vs 3.08 USD. This is not a temporal change — both observations claim to measure the same point in time. The ~10% discrepancy (0.35 USD difference) is material for a financial metric.
We flag conflicts openly ›
Recently verified
Checked against the original source
4,981
facts traced to their source — and we flag the ones that don't hold up.
101 entities tracked4,981 facts checked against source5,269 source documents archived
Query this data → isubstrate.com
Should You Buy, Sell or Hold NEM Stock After a 36% Rally in 6 Months? — Source | Via News | ViaNews EU